{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:52:35Z","timestamp":1771829555285,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.05.022","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:55:27Z","timestamp":1589234127000},"page":"637-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Angiotensin converting enzyme-2 as therapeutic target in COVID-19"],"prefix":"10.1016","volume":"14","author":[{"given":"Neda","family":"Roshanravan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samad","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.05.022_bib1","volume":"vol. 74","author":"Organization","year":"2020"},{"issue":"4","key":"10.1016\/j.dsx.2020.05.022_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dsx.2020.04.019","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during covid-19 pandemic","volume":"14","author":"Cure","year":"2020","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.05.022_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2020.04.006","article-title":"Oleoylethanolamide, a bioactive lipid amide, as a promising treatment strategy for coronavirus\/covid-19","author":"Ghaffari","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.dsx.2020.05.022_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2020.03.063","article-title":"The cardiovascular burden of coronavirus disease 2019 (covid-19) with a focus on congenital heart disease","volume":"15","author":"Tan","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.dsx.2020.05.022_bib5","article-title":"A\u00a0genomic perspective on the origin and emergence of sars-cov-2","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2020.05.022_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2020.04.008","article-title":"The impact of 2019 novel coronavirus on heart injury: a systemic review and meta-analysis","author":"Li","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.dsx.2020.05.022_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ace2 protein, the functional receptor for sars coronavirus. A first step in understanding sars pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J\u00a0Pathol: A Journal of the Pathological Society of Great Britain and Ireland"},{"issue":"2","key":"10.1016\/j.dsx.2020.05.022_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"Sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2020.05.022_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of covid-19","author":"Reynolds","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.dsx.2020.05.022_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5049\/EBP.2008.6.1.42","article-title":"Renin-angiotensin system - considerations for hypertension and kidney","volume":"6","author":"Yim","year":"2008","journal-title":"Electrolyte Blood Press"},{"issue":"5","key":"10.1016\/j.dsx.2020.05.022_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.117.09822","article-title":"Vascular adam17 (a disintegrin and metalloproteinase domain 17) is required for angiotensin ii\/beta-aminopropionitrile-induced abdominal aortic aneurysm","volume":"70","author":"Kawai","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.dsx.2020.05.022_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.116.07620","article-title":"Vascular adam17 as a novel therapeutic target in mediating cardiovascular hypertrophy and perivascular fibrosis induced by angiotensin ii","volume":"68","author":"Takayanagi","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.dsx.2020.05.022_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ace2\/angiotensin-(1-7)\/mas axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.dsx.2020.05.022_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ace2\/angiotensin-(1\u20137)\/mas axis of the renin-angiotensin system: focus on angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.dsx.2020.05.022_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.dsx.2020.05.022_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2020.05.022_bib17","series-title":"Recombinant human ace2: acing out angiotensin ii in ards therapy","author":"Zhang","year":"2017"},{"issue":"7","key":"10.1016\/j.dsx.2020.05.022_bib18","volume":"9","author":"Guo","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.dsx.2020.05.022_bib19","series-title":"Reference module in biomedical sciences: encyclopedia of endocrine diseases","article-title":"Interference with the renin-angiotensin system (ras): classical inhibitors and novel approaches","author":"Colafella","year":"2018"},{"key":"10.1016\/j.dsx.2020.05.022_bib20","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dsx.2020.05.022_bib21","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza a h5n1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.dsx.2020.05.022_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.dsx.2020.05.022_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A\u00a0pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.dsx.2020.05.022_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ace2: acing out angiotensin ii in ards therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.dsx.2020.05.022_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.dsx.2020.05.022_bib26","article-title":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (ncp)","author":"Wan","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.dsx.2020.05.022_bib27","series-title":"Discovery of anti-2019-ncov agents from 38 Chinese patent drugs toward respiratory diseases via docking screening","author":"Yan","year":"2020"},{"issue":"2","key":"10.1016\/j.dsx.2020.05.022_bib28","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.12912","article-title":"Analgesic effects of paracetamol and morphine after elective laparotomy surgeries","volume":"4","author":"Alimian","year":"2014","journal-title":"Anesthesiol Pain Med"},{"issue":"4","key":"10.1016\/j.dsx.2020.05.022_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/mol.111.076620","article-title":"Mechanisms of the inhibition of nuclear factor-kappab by morphine in neuronal cells","volume":"81","author":"Borner","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dsx.2020.05.022_bib30","unstructured":"England N, Improvement N. Primary care and community respiratory resource pack for use during covid-19."},{"key":"10.1016\/j.dsx.2020.05.022_bib31","first-page":"117","article-title":"Palliation in patients with severe covid-19","author":"Ekstr\u00f6m","year":"2020","journal-title":"Lakartidningen"},{"issue":"10223","key":"10.1016\/j.dsx.2020.05.022_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.dsx.2020.05.022_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031167","article-title":"Morphine suppresses ifn signaling pathway and enhances aids virus infection","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.dsx.2020.05.022_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"issue":"1","key":"10.1016\/j.dsx.2020.05.022_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CCM.0b013e31826767a8","article-title":"Opioid receptors control viral replication in the airways","volume":"41","author":"Salimi","year":"2013","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.dsx.2020.05.022_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/10673229309017075","article-title":"Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies","volume":"1","author":"Mello","year":"1993","journal-title":"Harv Rev Psychiatr"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:13:03Z","timestamp":1761729183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120301417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120301417"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.05.022","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin converting enzyme-2 as therapeutic target in COVID-19","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}